Pricing Log in Create free account

Acurx Pharmaceuticals, Inc. (ACXP) vs Pulmatrix, Inc. (PULM)

Acurx Pharmaceuticals, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and Pulmatrix, Inc. are of similar size ($5.3M and $5.1M). Across the 8 metrics below, Pulmatrix, Inc. leads on 6 and Acurx Pharmaceuticals, Inc. on 2.

Valuation

Metric ACXP PULM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.65 9.40
P/B 0.56 3.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.80 n/m 0.66
EV/Sales n/m 0.84 9.02
Earnings yield (290.18%) (79.14%) (32.88%)
Free cash flow yield (135.67%) (84.87%) (23.13%)

Profitability

Metric ACXP PULM Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (128.11%) (111.99%) (51.96%)
Return on assets (87.57%) (85.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACXP PULM Biotechnology median
Revenue growth (TTM) — 6.96% 6.76%
EPS growth (last fiscal year) 69.43% 46.18% 29.88%
Revenue growth, 5-year CAGR — (0.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACXP PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.88 4.70 4.97
Net debt to EBITDA 0.93 0.79 1.01

Dividend

Metric ACXP PULM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACXP PULM Biotechnology median
Market cap 5.26m 5.11m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack